ApexBio established in the Hsinchu Science-based Industrial Park since December 1997, the main products are used biosensor technology to create home care medical device for chronic disease patients to maintain and control their health. ApexBio successfully became the first IPO listed biotechnology company in 2000.
ApexBio was founded to develop into a full range of IVD company and is actively engaged in the research, development, manufacture and sales worldwide. At beginning using biosensor technology to develop a self-testing handheld blood glucose monitoring systems, uric acid, hemoglobin, cholesterol, lactate, HbA1C, ketone, coagulation and multifunctional self-testing systems. Our Products have been approved by CE, FDA, TFDA, CFDA, ANVISA and our manufacturing facilities also have been notified by Taiwan GMP, Brazil GMP, ISO 9001 & 13485, and FDA.
Our Developing Strategy
ApexBio is dedicated to become a leading IVD company and a total solution provider in healthcare.
Our Marketing Strategy
Enlarge our sales territory worldwide, and long-term cooperation with OEM/ODM/OBM customers to satisfy the demand of customers. And also alliance with vendors and customers to strengthen the partnership.